Sign Up to like & get
recommendations!
1
Published in 2017 at "Oncotarget"
DOI: 10.18632/oncotarget.22690
Abstract: Immune checkpoint blockades, such as inhibitors against programmed death 1 (PD-1) and its ligand (PD-L1), have received extensive attention in the past decade because of their dramatic clinical outcomes in advanced malignancies. However, both primary…
read more here.
Keywords:
pathway resistance;
regulation pathway;
resistance blockade;
blockade ... See more keywords